Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 725351, 7 pages
http://dx.doi.org/10.1155/2014/725351
Research Article

Serological and Histological Examination of a Nonalcoholic Steatohepatitis Mouse Model Created via the Administration of Monosodium Glutamate

1Fourth Department of Internal Medicine, Teikyo University Mizonokuchi Hospital, 3-8-3 Mizonokuchi, Takatsu-ku, Kawasaki-shi, Kanagawa 213-8507, Japan
2Department of Diagnostic Pathology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan
3Department of General Medical Practice and Laboratory Diagnostic Medicine, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita-shi, Akita 010-8543, Japan

Received 30 April 2014; Revised 16 July 2014; Accepted 31 July 2014; Published 30 October 2014

Academic Editor: Ancha Baranova

Copyright © 2014 Atsuko Takai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Shimada, E. Hashimoto, M. Taniai et al., “Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis,” Journal of Hepatology, vol. 37, no. 1, pp. 154–160, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Omagari, S. Morikawa, S. Nagaoka et al., “Predictive factors for the development or regression of fatty liver in Japanese adults,” Journal of Clinical Biochemistry and Nutrition, vol. 45, no. 1, pp. 56–67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Hashimoto, S. Yatsuji, H. Kaneda et al., “The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease,” Hepatology Research, vol. 33, no. 2, pp. 72–76, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Takahashi, Y. Soejima, and T. Fukusato, “Animal models of nonalcoholic fatty liver disease/ nonalcoholic steatohepatitis,” World Journal of Gastroenterology, vol. 18, no. 19, pp. 2300–2308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. W. Olney, “Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate,” Science, vol. 164, no. 3880, pp. 719–721, 1969. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Leitner and T. J. Bartness, “Food deprivation-induced changes in body fat mobilization after neonatal monosodium glutamate treatment,” American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 294, no. 3, pp. R775–R783, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Nakanishi, K. Tsuneyama, M. Fujimoto et al., “Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia,” Journal of Autoimmunity, vol. 30, no. 1-2, pp. 42–50, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Yamazaki, I. Usui, Y. Kanatani et al., “Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 297, no. 5, pp. E1179–E1186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. S. Collison, Z. M. Maqbool, A. L. Inglis et al., “Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat,” Obesity, vol. 18, no. 6, pp. 1122–1134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Sasaki, T. Shimada, S. Iizuka et al., “Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome,” European Journal of Pharmacology, vol. 662, no. 1–3, pp. 1–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Fujimoto, K. Tsuneyama, T. Fujimoto, C. Selmi, M. E. Gershwin, and Y. Shimada, “Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome,” Digestive and Liver Disease, vol. 44, no. 9, pp. 767–774, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Niedermeier, B. Reich, M. R. Gomez et al., “CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 42, pp. 17892–17897, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica, “Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes,” Trends in Immunology, vol. 23, no. 11, pp. 549–555, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Maina, S. Sutti, I. Locatelli et al., “Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice,” Clinical Science, vol. 122, no. 11, pp. 545–553, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. A. Huber, P. Sakkinen, C. David, M. K. Newell, and R. P. Tracy, “T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia,” Circulation, vol. 103, no. 21, pp. 2610–2616, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Fujimoto, K. Tsuneyama, Y. Nakanishi et al., “A dietary restriction influences the progression but not the initiation of MSG-Induced nonalcoholic steatohepatitis,” Journal of Medical Food, vol. 17, no. 3, pp. 374–383, 2014. View at Google Scholar
  17. T. Arndt, A. Rehorek, and F. Muller, “Assessment of cold induced alterations in catecholamine turnover of lean and glutamate-treated obese rats,” Experimental and Clinical Endocrinology, vol. 98, no. 3, pp. 207–211, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Alkhouri, L. J. Dixon, and A. E. Feldstein, “Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal,” Expert Review of Gastroenterology and Hepatology, vol. 3, no. 4, pp. 445–451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Caballero, A. Fernández, N. Matías et al., “Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione,” Journal of Biological Chemistry, vol. 285, no. 24, pp. 185228–185236, 2010. View at Google Scholar
  20. J. W. Haukeland, J. K. Damås, Z. Konopski et al., “Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2,” Journal of Hepatology, vol. 44, no. 6, pp. 1167–1174, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Tosello-Trampont, S. G. Landes, V. Nguyen, T. I. Novobrantseva, and Y. S. Hahn, “Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production,” Journal of Biological Chemistry, vol. 287, no. 48, pp. 40161–40172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, “Obesity induces a phenotypic switch in adipose tissue macrophage polarization,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 175–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Mathis and S. E. Shoelson, “Immunometabolism: an emerging frontier,” Nature Reviews Immunology, vol. 11, no. 2, pp. 81–83, 2011. View at Publisher · View at Google Scholar · View at Scopus